Shanghai Allist Pharmaceuticals
688578.SS
#2710
Rank
NZ$10.60 B
Marketcap
NZ$23.58
Share price
0.39%
Change (1 day)
71.75%
Change (1 year)

Operating Margin for Shanghai Allist Pharmaceuticals (688578.SS)

Operating Margin as of December 2025 (TTM): 45.49%

According to Shanghai Allist Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 45.49%. At the end of 2024 the company had an Operating Margin of 45.49%.

Operating Margin history for Shanghai Allist Pharmaceuticals from 2019 to 2025

Operating Margin at the end of each year

Year Operating Margin Change
202445.49%39.9%
202332.52%104.13%
202215.93%362.06%
20213.45%-100.01%
2020-55,361.44%-12.3%
2019-63,123.32%2894.31%
2018-2,108.11%318.39%
2017-503.87%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.